Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Forecast to 2026

Table of Contents

1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.2.1 Inclusion and Exclusion
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
1.4 Currency
1.5 Stakeholders
1.6 Summary of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insight
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
2.6 Limitations
2.7 Risk Assessment
2.8 Assessment of the Impact of COVID-19 on the Economic Scenario in the Animal Growth Promoters and Performance Enhancers Market

3 Executive Summary

4 Premium Insights
4.1 Animal Growth Promoters and Performance Enhancers Market Overview
4.2 Geographic Analysis: Animal Growth Promoters and Performance Enhancers Market
4.3 Animal Growth Promoters and Performance Enhancers Market: Geographic Growth Opportunities
4.4 Regional Mix: Animal Growth Promoters and Performance Enhancers Market (2019-2026)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in Demand and Consumption of Livestock-Based Products
5.2.1.2 Research into Alternatives to Antibiotics and Hormones and Increasing Demand for Non-Antibiotic Growth Promoters
5.2.1.3 Rise in the Global Demand for Naturally Produced Growth Promotors
5.2.1.4 Rise in Awareness About Growth Promotors
5.2.1.5 Rise in Animal Epidemics and Climate Changes
5.2.2 Restraints
5.2.2.1 Ban on Antibiotics in Different Nations
5.2.2.2 Stringent Regulations Restricting the Use of Antibiotics and Hormones for Growth Promotion in Animals
5.2.3 Opportunities
5.2.3.1 Focus on Increasing Environment Sustainability
5.2.4 Challenges
5.2.4.1 Increasing Global Feed Tonnage and High Feed Costs Leading to the Adoption of Conventional Feeding Systems
5.2.4.2 Growing Threat of Disease Transmission to and from Agricultural Animals

6 Industry Insights
6.1 Technology Analysis
6.2 Industry Trends
6.3 Pricing Analysis
6.4 Value Chain Analysis
6.5 Ecosystem Mapping
6.6 Supply Chain Analysis
6.7 Porter's Five Forces Analysis
6.8 Regulatory Analysis
6.9 Patent Analysis
6.9.1 Patent Publication Trends for Animal Growth Promoters and Performance Enhancers Market
6.10 Trade Analysis
6.11 Impact of COVID-19 on the Endoscopy Equipment Market

7 Animal Growth Promoters and Performance Enhancers Market, by Type
7.1 Introduction
7.2 Non-Antibiotic Growth Promoters and Performance Enhancers
7.2.1 Prebiotics & Probiotics
7.2.2 Acidifiers
7.2.3 Phytogenic
7.2.4 Feed Enzymes
7.2.5 Hormones
7.2.6 Other Non-Antibiotic Growth Promoters and Performance Enhancers
7.3 Antibiotic Growth Promoters

8 Animal Growth Promoters and Performance Enhancers T Market, by Animal Type
8.1 Introduction
8.2 Poultry
8.3 Swine
8.4 Livestock
8.5 Aquatic Animals
8.6 Other Animals

9 Animal Growth Promoters and Performance Enhancers Market, by Region
9.1 Introduction
9.2 Asia-Pacific
9.2.1 Japan
9.2.2 China
9.2.3 India
9.2.4 Australia
9.2.5 RoAPAC
9.3 North America
9.3.1 US
9.3.2 Canada
9.4 Europe
9.4.1 UK
9.4.2 Germany
9.4.3 Switzerland
9.4.4 Russia
9.4.5 RoE
9.5 Latin America
9.5.1 Brazil
9.5.2 Rest Latin America
9.6 Middle East
9.7 Africa

10 Competitive Landscape
10.1 Introduction
10.2 Revenue Analysis of Key Market Players
10.3 Market Share Analysis
10.4 Competitive Scenario
10.4.1 Product Launch
10.4.2 Deals
10.4.3 Other Development
10.5 Competitive Benchmarking
10.6 Company Evaluation Matrix
10.6.1 Stars
10.6.2 Emerging Leaders
10.6.3 Pervasive Players
10.6.4 Emerging Companies
10.7 Company Leadership Mapping (SME/Start-Ups)
10.7.1 Progressive Companies
10.7.2 Starting Blocks
10.7.3 Responsive Companies
10.7.4 Dynamic Companies
10.8 R&D Expenditure Assessment of Key Players
10.9 Geographical Revenue Assessment of Key Players

11 Company Profiles
11.1 Key Players
11.1.1 Cargill, Inc.
11.1.2 Royal DSM N.V.
11.1.3 Elanco Animal Health Inc.
11.1.4 Boehringer Ingelheim International GmbH
11.1.5 Merck & Co. Inc.
11.1.6 Alltech, Inc.
11.1.7 Archer-Daniels-Midland Company (ADM)
11.1.8 Vetoquinol
11.1.9 Bupo Animal Health
11.1.10 Novus International, Inc.
11.2 Other Players
11.2.1 Associated British Foods plc
11.2.2 Erber AG
11.2.3 Phibro Animal Health Corporation
11.2.4 Kemin Industries Inc.
11.2.5 Zoetis, Inc.
11.2.6 Nutreco N.V. (A Wholly Owned Subsidiary of SHV Group)
11.2.7 Novozymes A/S
11.2.8 BASFSE
11.2.9 Evonik Industries AG
11.2.10 Bluestar Adisseo Company
11.2.11 Land O’Lakes, Inc.
11.2.12 Chr. Hansen
11.2.13 Biomin Holding GmbH
11.2.14 Guangdong VTR Bio-Tech Co. Ltd.
11.2.15 Lallemand Inc.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: The Subscription Portal
12.3 Available Customizations

Companies Mentioned

• Alltech Corporation (US)
• Archer-Daniels-Midland Company (ADM) (US)
• Associated British Foods plc (UK)
• BASF SE (Germany)
• Biomin Holding GmbH (Austria)
• Bluestar Adisseo Company (China)
• Boehringer Ingelheim Group (Germany)
• Bupo Animal Health Pty. Ltd. (South Africa)
• Cargill Incorporated (US)
• Chr. Hansen (Denmark)
• Elanco Animal Health Incorporated (US)
• Erber AG (Austria)
• Evonik Industries AG (Germany)
• Guangdong VTR Bio-Tech Co. Ltd. (China)
• Kemin Industries Inc (US)
• Lallemand Inc. (Canada)
• Land O’Lakes Inc. (US)
• Merck & Co. Inc. (US)
• Novozymes A/S (Denmark)
• Novus International Inc. (US)
• Nutreco N.V. (Netherlands)
• Phibro Animal Health Corporation (US)
• Royal DSM N.V. (Netherlands)
• Vetoquinol S.A. (France)
• Zoetis Inc. (US)